Will 2023 be the year that pharma M&A makes a comeback?
January 12, 2023 at 13:29 PM EST
A handful of acquisitions this week point to a more deal-friendly year for biopharma and biotech companies.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following